Targeting the vascular interface: beyond crossing the blood-brain barrier靶向血管界面:超越血脑屏障的跨越Journal of Controlled ReleaseIF11.52026-09-010OAAI
Transient weakening of the blood-brain barrier in neonatal mice新生小鼠血脑屏障的暂时性减弱Fluids and Barriers of the CNSIF6.22026-08-110OA
Revisiting cerebral endothelial cells in Alzheimer's diseaseNEURAL REGENERATION RESEARCHIF6.72024-09-240OAAI
Local perfusion of capillaries reveals disrupted beta-amyloid homeostasis at the blood-brain barrier in Tg2576 murine Alzheimer's modelFLUIDS AND BARRIERS OF THE CNSIF6.22023-11-223OAAI
Subcellular analysis of blood-brain barrier function by micro-impalement of vessels in acute brain slicesNATURE COMMUNICATIONSIF15.72023-01-307OAAI
Stereotaxic-assisted gene therapy in Alzheimer's and Parkinson's diseases: therapeutic potentials and clinical frontiersEXPERT REVIEW OF NEUROTHERAPEUTICSIF3.42022-04-132PRE
Blood-brain barrier models: Rationale for selectionADVANCED DRUG DELIVERY REVIEWSIF17.62021-09-0128PRE
CRISPR/Cas9 Delivery Potentials in Alzheimer's Disease Management: A Mini ReviewPHARMACEUTICSIF5.52020-08-2520OAAI
Thermoresponsive Hyalomer intra-articular hydrogels improve monoiodoacetate-induced osteoarthritis in ratsINTERNATIONAL JOURNAL OF PHARMACEUTICSIF5.22020-01-0137PREAI
Micro- and nanotechnology approaches to improve Parkinson's disease therapy改善帕金森病治疗的微米和纳米技术方法JOURNAL OF CONTROLLED RELEASEIF11.52019-02-0150PREAI
Nanotechnology-based drug delivery systems for Alzheimer's disease management: Technical, industrial, and clinical challengesJOURNAL OF CONTROLLED RELEASEIF11.52017-01-01153OAAI
Pharmacological, toxicological and neuronal localization assessment of galantamine/chitosan complex nanoparticles in rats: future potential contribution in Alzheimer's disease managementDRUG DELIVERYIF8.12016-03-0478OAAI